Maria Luisa Biondi

Circa Diatech Pharmacogenetics

Questo autore non ha riempito alcun dettaglio.
Finora Diatech Pharmacogenetics ha creato 1081 post nel blog.

8 09, 2017

Rossella Bruno et al., Squamous cell transformation and EGFR T790M mutation as acquired resistance mechanisms in a patient with lung adenocarcinoma treated with a tyrosine kinase inhibitor: A case report. Oncology Letters

Diatech Pharmacogenetics2017-09-12T10:02:30+02:00

4 09, 2017

Diatech parteciperà all’ESMO 2017 a Madrid 8-12 settembre
Diatech parteciperà all’ESMO 2017 a Madrid 8-12 settembre

Notizie

Diatech parteciperà all’ESMO 2017 a Madrid 8-12 settembre

Diatech Pharmacogenetics2017-09-04T17:13:10+02:00

25 08, 2017

Deans ZC et al., Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers’ survey.

Diatech Pharmacogenetics2017-10-02T14:18:53+02:00

24 08, 2017

Annamaria Ruzzo et al., Dihydropyrimidine dehydrogenase pharmaco- genetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients. British Journal of Cancer

Diatech Pharmacogenetics2017-08-28T16:02:44+02:00

10 08, 2017

Gianni Bussolati et al., Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples. Plos One

Diatech Pharmacogenetics2017-08-28T15:42:16+02:00

19 07, 2017

Marco Lucarelli et al., A New Targeted CFTR Mutation Panel Based on Next-Generation Sequencing Technology. The Journal of Molecular Diagnostics

Diatech Pharmacogenetics2017-09-04T10:19:00+02:00

19 07, 2017

Francesca Galuppini et al., BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling. Histopathology

Diatech Pharmacogenetics2017-08-23T11:01:38+02:00

18 07, 2017

Federico Pessina et al., Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution. Future Medicine

Diatech Pharmacogenetics2017-08-03T11:05:28+02:00

8 07, 2017

Chiara Pesenti et al. Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status

Diatech Pharmacogenetics2017-09-14T09:58:03+02:00

7 07, 2017

1° Meeting Intermedio del Progetto PrInT-Age
1° Meeting Intermedio del Progetto PrInT-Age

Notizie

1° Meeting Intermedio del Progetto PrInT-Age

Diatech Pharmacogenetics2017-09-04T15:59:11+02:00

Precedente 282930 Successivo